Clinical Research Division, Fred Hutch
Dr. Michael Wagner is a medical oncologist who specializes in treating patients with sarcoma. He studies the molecular drivers of bone and soft tissue sarcomas and leads clinical trials of immunotherapy treatments, including checkpoint inhibitors, for patients with this rare group of diseases.
University of Washington School of Medicine
Fellowship, Medical Oncology, MD Anderson Cancer Center
Residency, Internal Medicine, Mount Sinai Medical Center
M.D., Harvard University
B.S., Duke University
To understand the molecular drivers of sarcomas and to translate this knowledge to develop clinical trials, ultimately leading to new treatments for this rare group of diseases